Results 71 to 80 of about 367,353 (219)
Cancer Management and Research, 2018 Wen Xiao, Xuegang Wang, Tao Wang, Jinchun Xing Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China Background and aim: Tripartite motif containing (TRIM) family protein has been involved in multiple ...
Xiao W, Wang X, Wang T, Xing J
doaj
Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma [PDF]
Virchows Archiv, 2009 We would like to thank Dr. Verine for his interest inour paper on renal angiomyoadenomatous tumors (RAT)[1] and for his letter to the editor [2]. Dr. Verine finds itunfortunate that we did not compare clear cell papillaryrenal cell carcinoma with RAT. In his view, clear cellpapillary renal cell carcinoma shares a lot of similaritieswith RAT, namely CK7,
Michal Michal +4 more
openaire +1 more source
Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma
Cell Discovery, 2022 The clear cell renal cell carcinoma (ccRCC) microenvironment consists of many different cell types and structural components that play critical roles in cancer progression and drug resistance, but the cellular architecture and underlying gene regulatory ...
Zhilin Long +10 more
semanticscholar +1 more source
Siriraj Medical Journal, 2016 Objective: To differentiate clear cell and non-clear cell renal cell carcinoma (RCC) using enhancement pattern, relative enhancement ratio and associated findings on CT scan.
Nithida Na Songkhla
doaj +2 more sources
Metastatic Renal Cell Carcinoma in the Sinonasal Region [PDF]
, 2013 Sinonasal region is an exceptional site for metastatic tumors. Renal cell carcinoma is known to metastasise to the most unusual sites, the sinonasal region being one of them. Clear cell carcinoma is its most common histologic variant.
Mahantachar, V, Raj, JA, Rajaram, T
core +1 more source
Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
European Urology, 2022 CONTEXT Although antiangiogenic treatments and immunotherapies have significantly improved the prognosis of metastatic renal cell carcinoma (RCC), many patients will develop resistance, leading to treatment failure. Genetic tumor heterogeneity is a major
Thi Oanh Bui +5 more
semanticscholar +1 more source
Molecular Therapy: Nucleic Acids, 2022 MEX3A is an RNA-binding protein that mediates mRNA decay through binding to 3′ untranslated regions. However, its role and mechanism in clear cell renal cell carcinoma remain unknown.
Yuntan Qiu +19 more
doaj +1 more source
A case of multilocular cystic renal cell carcinoma diagnosed by pharmacoangiography [PDF]
, 1994 A case of multilocular cystic renal cell carcinoma in a 62-year-old man was reported. He was admitted with complaint of asymptomatic gross hematuria. Abdominal ultrasonography and CT scan revealed multilocular cystic mass at the lower pole of the right ...
三木, 誠 +4 more
core
CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib [PDF]
, 2017 BACKGROUND: To assess CT texture based quantitative imaging biomarkers in the prediction of progression free survival (PFS) and overall survival (OS) in patients with clear cell renal cell carcinoma undergoing treatment with Sunitinib.
Bjarnason, GA +5 more
core +1 more source
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Cancer DiscoveryCTX130, an allogeneic CD70-targeting CAR-T cell therapy, yielded disease control in the majority of patients with clear cell renal cell carcinoma treated in a phase I clinical trial, with one patient obtaining a durable complete remission.
S. Pal +24 more
semanticscholar +1 more source